Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056
Clinical trial NCT01296711 · TERMINATED
Trial details
- NCT number
- NCT01296711
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-07
- Primary completion
- 2013-05-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.